Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1996
10/30/1996EP0739353A1 Bacterial receptor structures
10/30/1996EP0739352A1 New composition of glycoprotein isoforms having follicle stimulating activity
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0739214A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
10/30/1996EP0739212A1 Use of interleukin-12 to prevent graft versus host disease
10/30/1996EP0739211A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
10/30/1996EP0647277A4 Methods for using cks fusion proteins.
10/30/1996EP0592476B1 Use of interleukine 10 to produce drugs with a tumour-inhibiting action
10/30/1996EP0527852B1 Method and compositions for treating injury
10/30/1996EP0512071B1 Method and compositions for inhibiting angiogenesis
10/30/1996EP0487613B1 A megakaryocytopoietic factor
10/30/1996EP0479909B1 Bispecific reagents for aids therapy
10/30/1996CN1134728A Subtilisin BPN' variants with decreased adsorption and increased hydrolysis
10/30/1996CN1134707A Peptide and antithrombotic agent
10/30/1996CN1134706A Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
10/30/1996CN1134704A Drug binding protein
10/30/1996CN1134461A Rabbit hemorrhagic disease virus (RHDV) recombinant capsids and proteins, diagnostic kits and vaccines containing said RHDV recombinant capsids and proteins
10/30/1996CN1134460A HTFIIIA gent
10/29/1996US5569830 Plant inhibitors of fungal polygalacturonases and their use to control fungal disease
10/29/1996US5569829 Sense or antisense rna technology to control gene expression, increased solids contents
10/29/1996US5569828 Maize chlorotic dwarf virus and resistance thereto
10/29/1996US5569827 Transgenic mouse for the neuronal expression of HIV gp160
10/29/1996US5569825 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
10/29/1996US5569824 Tumor susceptible
10/29/1996US5569823 DNA comprising plum pox virus and tomato spotted wilt virus cDNAS for disease resistance
10/29/1996US5569768 Angiotensin II antagonists
10/29/1996US5569755 Antitumor agents
10/29/1996US5569744 A modified polypeptide; reduced risk for diabetes type ii, cardiovascular disorder and cancer; regulates fat tissues
10/29/1996US5569743 Anti-obesity proteins
10/29/1996US5569742 Centrally truncated NPY cyclic peptides
10/29/1996US5569741 Cyclic octapeptide neuromedin B receptor antagonists
10/29/1996US5569680 Administering to inhibit the production of interleukin-8 in intestinal epithelial cells
10/29/1996US5569647 Angiopeptin cyclopeptide compounds
10/29/1996US5569604 Calcitonin/calcitonin gene related peptide enhancer element and associated DNA binding proteins
10/29/1996US5569603 Parasiticide
10/29/1996US5569601 Human dopamine receptor and its uses
10/29/1996US5569598 Extracellular aminopeptidase isolated from Streptococcus thermonitrificans culture
10/29/1996US5569595 Production of poly-β-hydroxybutyrate in prokaryotic host cells
10/29/1996US5569584 Method for distinguishing or monitoring the state of premalignant or malignant transformed human colonic tissue
10/29/1996US5569454 Methods of treating infection using natural killer stimulatory factor
10/29/1996CA2175115A1 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
10/29/1996CA1338682C Biologically active undenatured whey protein concentrate as food supplement
10/25/1996EP0712936A4 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
10/24/1996WO1996033416A1 Methods of screening for therapeutic agents using novel apoptosis-modulating proteins
10/24/1996WO1996033414A2 Compounds and methods for diagnosis of leishmaniasis
10/24/1996WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996WO1996033281A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996WO1996033278A1 New cathepsin c homolog
10/24/1996WO1996033276A1 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF
10/24/1996WO1996033275A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE
10/24/1996WO1996033274A1 Helicobacter pylori cagi region
10/24/1996WO1996033273A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/24/1996WO1996033272A1 Vectors for the transfection of eucaryotic cells, their use and target cells transfected thereby
10/24/1996WO1996033271A2 Genetic markers for breast and ovarian cancer
10/24/1996WO1996033270A1 Structure-based designed herbicide resistant products
10/24/1996WO1996033269A1 Vectors and prokaryotes which autocatalytically delete antibiotic resistance
10/24/1996WO1996033220A1 Protective helicobacter antigens
10/24/1996WO1996033219A1 Monoclonal antibodies against hiv-1 and vaccines made thereof
10/24/1996WO1996033218A1 Anti-haemorrhagic peptides
10/24/1996WO1996033217A1 Cell adhesion protein, immunosuppressive agent containing the same, and immunosuppressive agent containing cells induced thereby
10/24/1996WO1996033216A1 Truncated igf-i
10/24/1996WO1996033215A1 Novel protein and process for producing the same
10/24/1996WO1996033214A2 Altered protein expression in hypoxic trophoblasts
10/24/1996WO1996033206A1 Conotoxin peptides
10/24/1996WO1996032963A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
10/24/1996WO1996032962A1 Immunoassay for herpes simplex virus
10/24/1996WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996WO1996032958A1 Method for treatment of pain
10/24/1996WO1996032957A1 Modulation of cytokine patterns of human autoreactive t-cell clones
10/24/1996WO1996032956A1 p19: A CELL CYCLE INHIBITOR
10/24/1996WO1996032955A1 Neuropeptide y analogs
10/24/1996WO1996032954A1 Nitrosylated neuropeptides
10/24/1996WO1996032932A1 Dna vaccines against rotavirus infections
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996WO1996028549A3 Hyaluronan receptor expressed in human umbilical vein endothelial cells
10/24/1996WO1996027128A3 Hiv determinants required for in vivo replication
10/24/1996WO1996020278A3 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
10/24/1996WO1996016982A3 Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
10/24/1996WO1996011562A3 Human checkpoint gene and gene for antisense rna thereof
10/24/1996DE19515327A1 Antitumour agents comprising new poly:peptide(s)
10/24/1996DE19514310A1 Vektoren zur Transfektion von eukaryotischen Zellen, deren Verwendung und damit transfizierte Zielzellen Vectors for transfection of eukaryotic cells, their use and thus transfected target cells
10/24/1996CA2218741A1 Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218618A1 Method for treatment of pain
10/24/1996CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996CA2218585A1 H. influenzae hxub and hxuc genes, proteins and methods of use
10/24/1996CA2218535A1 Altered protein expression in hypoxic trophoblasts
10/24/1996CA2218385A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
10/24/1996CA2217496A1 Protective helicobacter antigens
10/24/1996CA2217010A1 New cathepsin c homolog
10/24/1996CA2216936A1 Modulation of cytokine patterns of human autoreactive t-cell clones
10/24/1996CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996CA2216751A1 Conotoxin peptides
10/23/1996EP0738736A1 Monoclonal antibodies to gp130, and their uses
10/23/1996EP0738735A2 Aminoterminal propeptide of type I procollagen, antibody thereto and assay method using it
10/23/1996EP0738734A1 NOVEL RECOMBINANT DerI ALLERGENIC SUBSTANCE, PRECURSOR THEREOF, AND PROCESS FOR PRODUCING THEM
10/23/1996EP0738332A1 Indicator cell line for detecting rna viruses and method therefor
10/23/1996EP0738329A1 Hybrid cytokines
10/23/1996EP0738325A1 Receptor specific bacterial adhesins and their use